17.10.2005 13:00:00

IntraLase Enhances Product Development Capability with Key Appointment

IntraLase Corp. (NASDAQ:ILSE) today announced that ithas hired Michael Brownell as vice president, product development. Inhis newly created position, Brownell will be responsible forleveraging and innovating IntraLase's industry-leading, core lasertechnology platform. He will report to Charline Gauthier, executivevice president and chief operating officer.

"Over his 18-year career, Michael has distinguished himself as anexpert in the area of laser product development," said Gauthier. "I amconfident that IntraLase will benefit from his fresh perspective anddynamic leadership skills. His depth of start-up experience -- whichincludes the early years of IntraLase where he led the developmentefforts of our initial femtosecond laser product -- also lends anentrepreneurial spirit that we value very highly within theorganization."

Brownell most recently served as chief technology officer andexecutive board member at Powerlase, a U.K.-based manufacturer ofhigh-power short-pulsed lasers for materials processing andnext-generation lithography markets. In that role, he was responsiblefor spearheading the company's product development initiatives, aswell as technology roadmaps, engineering management, intellectualproperty management and operations development. He has also held avariety of positions in the areas of product development and marketingat companies such as GigaTera, New Focus and KLA Instruments.

Brownell received an M.S. in physics with an emphasis on modernoptics and lasers as well as a B.S. degree in scientificinstrumentation, both from San Diego State University in San Diego.

About IntraLase Corp.:

IntraLase designs, develops and manufactures an ultra-fast laser,related software and disposable devices used to create a corneal flap,the first step in LASIK surgery for the correction of vision. Thecompany's products improve the safety, precision and visual results ofLASIK procedures by providing a computer-controlled laser solution inplace of the hand-held mechanical, metal-bladed microkeratometraditionally used to create corneal flaps. IntraLase lasers are alsoused in surgical approaches to the treatment of diseased corneas. Thecompany's lasers and disposable per procedure patient interfaces arepresently marketed throughout the United States and 21 othercountries. IntraLase has headquarters and manufactures its products inIrvine. For additional information, visit the company's Web site:www.intralase.com.

Forward-Looking Statements:

Statements contained in this press release that are not historicalinformation are forward-looking statements as defined within thePrivate Securities Litigation Reform Act of 1995. Forward-lookingstatements can be identified by the use of words such as "believe,""expect," "anticipate," "intend," "plan," "estimate," "project," orwords of similar meaning, or future or conditional verbs such as"will," "would," "should," "could," or "may." Such forward-lookingstatements are subject to risks and uncertainties that could causeactual results to differ materially from those projected or implied.Those risks and uncertainties include, but are not limited to: thedegree of continued acceptance of LASIK surgery; potentialcomplications revealed by long-term follow up; the extent of adoptionof our product offering by LASIK surgeons; general economicconditions; changes in federal tax laws governing the ability ofpotential LASIK patients to use pre-tax dollars to pay for LASIKsurgery; the scope of government regulation applicable to ourproducts; patients' willingness to pay for LASIK surgery; our abilityto compete against our competitors; the effectiveness of our measuresto ensure full payment of procedure fees; the occurrence and outcomeof product liability suits against us; our ability to adequatelyprotect our intellectual property; whether we become subject to claimsof infringement or misappropriation of the intellectual propertyrights of others; the continued availability of supplies fromsingle-source suppliers and manufacturers of our key laser components;the ability of our managers, operations, and facilities to manage ourgrowth; the success of our expansion into markets outside the UnitedStates; whether we lose any of our key executives or fail to attractqualified personnel; or if our new products or applications fail tobecome commercially viable.

Certain of these risks and uncertainties, in addition to otherrisks, are more fully described in the company's quarterly report onform 10-Q for the period ending June 30, 2005, as filed with theSecurities and Exchange Commission on Aug. 10, 2005.

These forward-looking statements are made only as of the date ofthis press release, and the company assumes no obligation to update orrevise the forward-looking statements, whether as a result of newinformation, future events, or otherwise.

JETZT DEVISEN-CFDS MIT BIS ZU HEBEL 30 HANDELN
Handeln Sie Devisen-CFDs mit kleinen Spreads. Mit nur 100 € können Sie mit der Wirkung von 3.000 Euro Kapital handeln.
82% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren.

Nachrichten zu IntraLase Corp.mehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu IntraLase Corp.mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Indizes in diesem Artikel

NASDAQ Comp. 19 290,69 -0,97%